Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1382 per EA under NDC 31722094205. Its NADAC has been published 372 times since Jul 10, 2019.

FDA first approved this application on Nov 7, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1382per EA
DEA Schedule CII

Strength

325; 7.5 mg/1; mg/1

NDC

31722094205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211487

FDA Approved

11/7/2018

TE Code

AA

On Market Since

8/22/2025

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 372 times since Jul 10, 2019, and over the history we have for it it has risen 31.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1382 per EA
All-time high$0.1630 (Jul 10, 2024)
All-time low$0.0932 (Dec 18, 2019)
52-week high$0.1533
52-week low$0.1379
Median price$0.1325
Average price$0.1324
Largest weekly change+41.5% (Jan 22, 2020)
Weeks tracked372
Tracking sinceJul 10, 2019

Price History

1W

-0.5%

1M

-0.5%

3M

+0.1%

6M

-0.3%

1Y

-9.8%

3Y

-3.1%

5Y

+5.9%

All

+31.6%

Generic Alternatives

The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1382 per EA (NDC 31722094205), effective Aug 19, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has risen 31.6%. It has been tracked across 372 weekly CMS publications since Jul 10, 2019.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Since Jul 10, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1630 (Jul 10, 2024), with a median of $0.1325 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 8% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 31722094205) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.